GLPG (Galapagos NV) Utang jangka cendhak marang modal
The historical price chart for Galapagos NV (GLPG) on GURU.Markets demonstrates financial resilience regarding the 0.00 metric, as colossal cash reserves offset research and development costs. The business relies on payments from industry behemoths and the development of new medications for cancer and autoimmune pathologies. Growth is driven by mergers with biotech projects and the launch of joint cell therapy programs.
Rincian analitis perusahaan Galapagos NV
- kuotasi lan prakiraan analis:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Galapagos NV|GLPG - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Galapagos|GLPG - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Galapagos N.V.|GLPG - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Galapagos|Rasio cepet glpg.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Pambiji fundamental:GLPG Galapagos Genomics
It is critical for investors to assess the stability of Galapagos NV through the ratio of liabilities maturing within one year to equity, which determines the extent to which expansion depends on borrowed funds. By analyzing the volume of short-term loans relative to equity, one can confirm a low risk of liquidity gaps, as the company's multi-billion dollar cash reserves completely neutralize the pressure of current debts and cover R&D costs.
Pesaing Galapagos NV (GLPG)
Utang jangka cendhak marang modal HLN|KVUE (Kenvue Health) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal VRNA (Verona Pharma plc)|Utang jangka cendhak marang modal jyongbio.com MENS|LGND - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal anipharmaceuticals.com|Rasio utang jangka cendhak marang ekuitas MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Pacira PCRX|ARS Corp (SPRY) - Kewajiban jangka cendhak marang modal|TBPH: Rasio utang jangka cendhak marang ekuitas|aquestive.com - Rasio silihan jangka cendhak marang modal|SCPH: Utang jangka cendhak marang modal|Tectonic Therapeutic - Rasio tanggungan utang jangka cendhak marang modal|TNXP (Tonix Pharmaceuticals Inc.) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal SXT China SXTC|Utang jangka cendhak marang ekuitas Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal EXOZ (eXoZymes)|Tanggungan utang jangka cendhak marang ekuitas Oramed|Entera Bio Corp - Utang jangka cendhak marang modal|HYFT - Utang jangka cendhak marang modal|ABVC BioPharma (ABVC) - Utang jangka cendhak marang ekuitas|CPIX (cumberlandpharma.com) - Utang jangka cendhak marang ekuitas|QNTM (Quantum BioPharma) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal FibroGen Inc|Utang jangka cendhak marang ekuitas Telomir Pharma (TELO)|RANI: Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang modal SNYR (Synergy CHC)|Utang jangka cendhak marang modal Rallybio Corp RLYB|Lexaria - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas Pulmatrix Inc (PULM)|ftzy.com.cn (PTHL) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Aptorum Group (APM)|Utang jangka cendhak marang ekuitas Lyra Therapeutics, Inc.|impactbiomedinc.com (IBO) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas TNFA (TNF Pharmaceuticals)|YCBD (cbdmd.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas PainReform Limited PRFX|CYTO: Rasio utang jangka cendhak marang modal|LIPO: Rasio utang jangka cendhak marang ekuitas|OPTN: Utang jangka cendhak marang ekuitas|PIRS: Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas Procaps Group PROC|Utang jangka cendhak marang ekuitas Petros|Utang jangka cendhak marang ekuitas QLI|Utang jangka cendhak marang ekuitas Acelyrin, Inc. (SLRN)|TFFP: Kewajiban jangka cendhak marang ekuitas